Systemic inflammation shapes clinical outcomes in response to immune checkpoint blockade treatment: moving toward optimizing antitumor immunity.

J Immunother Cancer · 2023 · PMC10008381 · PMID 36889809

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

An overall trend of significantly worse clinical outcomes was observed in patients with lower or higher NLR levels than the reference group (NLR=2.00–2.99) ( figure 5A, B ). 10.1136/jitc-2022-006462.supp1 Supplementary data 10.1136/jitc-2022-006462.supp2 Supplementary data 10.1136/jitc-2022-006462.supp3 Sup

also in 4,285 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.